November 12, 2007 – At RSNA 2007, Advanced Research Technologies will showcase the SoftScan optical imaging device, designed for the detection, diagnosis and characterization of breast cancer.

The device provides functional or physiological information about a lesion, such as tissue perfusion and blood oxygen content, which the company says allows characterization of a lesion as benign or malignant.

Use of the device does not involve painful compression of the breast or ionizing radiation. It can image women with dense breast tissue or who have undergone hormonal therapy, and reportedly reduces the need for painful biopsies.

The SoftScan system includes a patient table, scanning accessories, an optical acquisition unit, and a processing and display workstation installed on a separate mobile unit. The system can be installed in any clinical setting similar in size to a stereotactic biopsy suite.

For more information: www.art.ca


Additional Content

News | FDA

April 16, 2026 — Royal Philips has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral ...

Time April 20, 2026
arrow
News | Radiation Oncology

Jan. 8, 2026 — RefleXion Medical, an external-beam theranostic oncology company, has announced the U.S. Food and Drug ...

Time January 13, 2026
arrow
News | Prostate Cancer

Nov. 10, 2025 — Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a ...

Time November 11, 2025
arrow
News | Breast Imaging

July 29, 2025 — A new technology that harnesses AI to analyze mammograms and improve the accuracy of predicting a woman ...

Time July 30, 2025
arrow
News | Imaging Software Development

June 12, 2025 — GE HealthCare has announced the combination of GE HealthCare’s proprietary features and algorithms with ...

Time June 12, 2025
arrow
Subscribe Now